New Hampshire HB 1225: relative to prescription drug affordability board conflicts of interest.

Status: Interim Study Report: Not Recommended for Future Legislation (Vote 16-0) (as of 2024-10-31)

State: New Hampshire · Session: 2024 · Bill: HB 1225

Sponsors: Jess Edwards, Daryl Abbas

View New Hampshire HB 1225 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.